| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |